This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Bet on These 5 Top-Ranked Liquid Stocks for Fat Returns
by Radhika Pujara
Here are five top-ranked liquid stocks, including Nu Skin Enterprises (NUS), that investors can snap up for enhancing portfolio returns.
Is Nu Skin Enterprises (NUS) a Good Value Investor Stock?
by Zacks Equity Research
Let's see if Nu Skin Enterprises (NUS) stock is a good choice for value-oriented investors right now from multiple angles.
NUS vs. EL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Nu Skin is Poised on Customer Base Growth & Product Pipeline
by Zacks Equity Research
Strength in Nu Skin's (NUS) customer base driven by its effective strategies is yielding. Also, it is focused on empowering sales leaders through engaging technology platforms.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
Inter Parfums Down on 2020 View, Travel Retail Woes to Stay
by Zacks Equity Research
Inter Parfums (IPAR) expects net sales of roughly $442 million for 2020, indicating a decline from 2019 levels. Travel retail is likely to remain under pressure.
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Here's Why Nu Skin Stock is Up More Than 20% in Three Months
by Zacks Equity Research
Nu Skin (NUS) is seeing robust growth in its customer base courtesy of its effective strategies. Also, management recently raised its 2020 outlook.
Nu Skin (NUS) Up 0.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: IBP, MED, NUS and LOGI
by Zacks Equity Research
Zacks.com featured highlights include: IBP, MED, NUS and LOGI
4 Best-Performing Liquid Stocks for Alluring Returns
by Radhika Pujara
Here are four excellent liquid stocks, including Logitech (LOGI), that can contribute to making an outstanding portfolio for investors.
Coty (COTY) Down on Wider-Than-Expected Q4 Loss & Drab Sales
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2020 results reflect adverse impacts of coronavirus-led retail and salon closures. The company expects to return to profits in the first quarter of fiscal 2021.
6 Stocks Near 52-Week Highs That Can Carry The Momentum Further
by Anirudha Bhagat
Investors will target stocks that have been on a bullish run lately. Stocks seeing price strength have higher chances of carrying the momentum forward.
NUS vs. HELE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Inter Parfums (IPAR) in Focus: Stock Moves 6.9% Higher
by Zacks Equity Research
Inter Parfums (IPAR) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Altria Gains From Oral Products Amid Lower Cigarette Sales
by Zacks Equity Research
Despite dismal cigarette sales, pricing power and growth in oral tobacco are offering Altria (MO) some respite.
Estee Lauder's (EL) Q4 Loss Wider Than Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) fourth-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures. The company launches a two-year plan called Post-COVID Business Acceleration Program.
Nu Skin, AZZ, Regal Beloit and Rexnord highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nu Skin, AZZ, Regal Beloit and Rexnord highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Nu Skin (NUS)
by David Bartosiak
A big jump in earnings estimates means this stock deserves a new look.
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Philip Morris Extends Deal With KT&G, RRPs Expansion on Track
by Zacks Equity Research
Philip Morris (PM) will start commercialization of KT&G's smoke-free alternatives outside South Korea, beginning with Russia.
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin